Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct 1;29(5):1401-1417.
doi: 10.1212/CON.0000000000001291.

Diabetic Neuropathies

Diabetic Neuropathies

Melissa A Elafros et al. Continuum (Minneap Minn). .

Abstract

Objective: This article provides an up-to-date review of the diagnosis and management of the most common neuropathies that occur in patients with diabetes.

Latest developments: The prevalence of diabetes continues to grow worldwide and, as a result, the burden of diabetic neuropathies is also increasing. Most diabetic neuropathies are caused by hyperglycemic effects on small and large fiber nerves, and glycemic control in individuals with type 1 diabetes reduces neuropathy prevalence. However, among people with type 2 diabetes, additional factors, particularly metabolic syndrome components, play a role and should be addressed. Although length-dependent distal symmetric polyneuropathy is the most common form of neuropathy, autonomic syndromes, particularly cardiovascular autonomic neuropathy, are associated with increased mortality, whereas lumbosacral radiculoplexus neuropathy and treatment-induced neuropathy cause substantial morbidity. Recent evidence-based guidelines have updated the recommended treatment options to manage pain associated with distal symmetric polyneuropathy of diabetes.

Essential points: Identifying and appropriately diagnosing the neuropathies of diabetes is key to preventing progression. Until better disease-modifying therapies are identified, management remains focused on diabetes and metabolic risk factor control and pain management.

PubMed Disclaimer

Figures

Figure 1:
Figure 1:
Graphs for two separate patients depicting heart rate response to deep breathing – (A) is for the patient in Case 2, compared to (B) a normal study. This test is an assessment of parasympathetic cardiovagal function. The heart rate increases at the end of inspiration and decreases at the end of expiration. The R-R interval is the distance in milliseconds between successive QRS complexes on a single-lead ECG tracing. A graph of the R-R interval versus time should have a clear sinusoidal shape that mimics the patient’s respiratory rate, as seen in (B), when parasympathetic cardiovagal function is intact. This response is blunted in the patient from Case 2 as seen in (A).
Figure 2:
Figure 2:
Nerve conduction studies show decreased CMAPs in the left tibial and peroneal motor nerves as well as an absent sural sensory response. There is increased positive sharpwaves and fibrillations in muscles in the left leg with absent voluntary motor unit action potentials in muscles innervated by the peroneal, tibial, obturator, and femoral nerves. There is asymmetry between the sides. These findings are typical for diabetic lumbosacral radiculoplexus neuropathy.
Figure 3:
Figure 3:
MRI without contrast of the pelvis in a patient with asymmetric leg weakness. Asymmetric increased T2 signal and thickening of the left lumbosacral plexus coronal STIR image (A) and thickening of the left femoral nerve on the axial FLAIR (B). In the appropriate clinical context, these findings are consistent with a diagnosis of diabetic lumbosacral radiculoplexus neuropathy.

References

    1. International Diabetes Federation. IDF Diabetes Atlas: International Diabetes Federation, 2021.
    1. Gylfadottir SS, Christensen DH, Nicolaisen SK, et al. Diabetic polyneuropathy and pain, prevalence, and patient characteristics: a cross-sectional questionnaire study of 5,514 patients with recently diagnosed type 2 diabetes. Pain 2020; 161(3): 574–83. - PMC - PubMed
    1. Gordois A, Scuffham P, Shearer A, Oglesby A, Tobian JA. The health care costs of diabetic peripheral neuropathy in the US. Diabetes Care 2003; 26(6): 1790–5. - PubMed
    1. Callaghan BC, Price RS, Feldman EL. Distal Symmetric Polyneuropathy: A Review. JAMA 2015; 314(20): 2172–81. - PMC - PubMed
    1. Abbott CA, Malik RA, van Ross ER, Kulkarni J, Boulton AJ. Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K. Diabetes Care 2011; 34(10): 2220–4. - PMC - PubMed